Biological Principles and Clinical Issues Underlying Liver Transplantation for Virus-Induced End-Stage Liver Disease

James R. Burton, Hugo R. Rosen, Paul Martin

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationThe Liver
Subtitle of host publicationBiology and Pathobiology: Fifth Edition
PublisherJohn Wiley & Sons, Ltd
Pages921-931
Number of pages11
ISBN (Print)9780470723135
DOIs
StatePublished - Oct 6 2009

Keywords

  • Antiviral treatment strategies for recurrent HCV
  • Factors associated with severe HCV recurrence
  • Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) study
  • Hepatitis C virus (HCV)-related end-stage liver disease
  • Liver transplantation for hepatitis B virus (HBV) infection
  • Liver transplantation for virus-induced end-stage liver disease-biological principles and clinical issues
  • Preemptive antiviral therapy
  • Retransplantation for allograft cirrhosis
  • Risk of acute cellular rejection
  • Vaccination as strategy to protect transplant recipients against HBV infection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Burton, J. R., Rosen, H. R., & Martin, P. (2009). Biological Principles and Clinical Issues Underlying Liver Transplantation for Virus-Induced End-Stage Liver Disease. In The Liver: Biology and Pathobiology: Fifth Edition (pp. 921-931). John Wiley & Sons, Ltd. https://doi.org/10.1002/9780470747919.ch55